Literature DB >> 3030729

The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms.

C Cladaras, M Hadzopoulou-Cladaras, R T Nolte, D Atkinson, V I Zannis.   

Abstract

We have isolated and sequenced overlapping cDNA clones covering the entire sequence of human apolipoprotein B-100 (apoB-100). DNA sequence analysis and determination of the mRNA transcription initiation site by S1 nuclease mapping showed that the apoB mRNA consists of 14,112 nucleotides including the 5' and 3' untranslated regions which are 128 and 301 nucleotides respectively. The DNA-derived protein sequence shows that apoB-100 is 513,000 daltons and contains 4560 amino acids including a 24-amino-acid-long signal peptide. The mol. wt of apoB-100 implies that there is one apoB molecule per LDL particle. Computer analysis of the predicted secondary structure of the protein showed that some of the potential alpha helical and beta sheet structures are amphipathic, whereas others have non-amphipathic neutral to apolar character. These latter regions may contribute to the formation of the lipid-binding domains of apoB-100. The protein contains 25 cysteines and 20 potential N-glycosylation sites. The majority of cysteines are distributed in the amino terminal portion of the protein. Four of the potential glycosylation sites are in predicted beta turn structures and may represent true glycosylation positions. ApoB lacks the tandem repeats which are characteristic of other apolipoproteins. The mean hydrophobicity the mean value of H1 and helical hydrophobic moment the mean value of microH profiles of apoB showed the presence of several potential helical regions with strong polar character and high hydrophobic moment. The region with the highest hydrophobic moment, between amino acid residues 3352 and 3369, contains five closely spaced, positively charged residues, and has sequence homology to the LDL receptor binding site of apoE. This region is flanked by three neighbouring regions with positively charged amino acids and high hydrophobic moment that are located between residues 3174 and 3681. One or more of these closely spaced apoB sequences may be involved in the formation of the LDL receptor-binding domain of apoB-100. Blotting analysis of intestinal RNA and hybridization of the blots with carboxy apoB cDNA probes produced a single 15-kb hybridization band whereas hybridization with amino terminal probes produced two hybridization bands of 15 and 8 kb. Our data indicate that both forms of apoB mRNA contain common sequences which extend from the amino terminal of apoB-100 to the vicinity of nucleotide residue 6300. These two messages may have resulted from differential splicing of the same primary apoB mRNA transcript.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3030729      PMCID: PMC1167386          DOI: 10.1002/j.1460-2075.1986.tb04675.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  64 in total

1.  Isolation of multigene families and determination of homologies by filter hybridization methods.

Authors:  G A Beltz; K A Jacobs; T H Eickbush; P T Cherbas; F C Kafatos
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

2.  Human apolipoprotein B: partial amino acid sequence.

Authors:  R C LeBoeuf; C Miller; J E Shively; V N Schumaker; M A Balla; A J Lusis
Journal:  FEBS Lett       Date:  1984-05-07       Impact factor: 4.124

Review 3.  Three-dimensional structure of membrane and surface proteins.

Authors:  D Eisenberg
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

4.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

5.  Comparison of alpha-tropomyosin sequences from smooth and striated muscle.

Authors:  N Ruiz-Opazo; J Weinberger; B Nadal-Ginard
Journal:  Nature       Date:  1985 May 2-8       Impact factor: 49.962

6.  Measurement in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta. Predominance of intimal degradation.

Authors:  T E Carew; R C Pittman; E R Marchand; D Steinberg
Journal:  Arteriosclerosis       Date:  1984 May-Jun

7.  Isolation and characterization of the human apolipoprotein A-I gene.

Authors:  S K Karathanasis; V I Zannis; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.

Authors:  T Yamamoto; C G Davis; M S Brown; W J Schneider; M L Casey; J L Goldstein; D W Russell
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

9.  Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha.

Authors:  D C Lee; T M Rose; N R Webb; G J Todaro
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

10.  Molecular weights of apoprotein B obtained from human low-density lipoprotein (apoprotein B-PI) and from rat very low density lipoprotein (apoprotein B-PIII).

Authors:  J Elovson; J C Jacobs; V N Schumaker; D L Puppione
Journal:  Biochemistry       Date:  1985-03-12       Impact factor: 3.162

View more
  39 in total

1.  Tandem mass spectrometric characterization of a specific cysteic acid residue in oxidized human apoprotein B-100.

Authors:  O Burlet; C Y Yang; J R Guyton; S J Gaskell
Journal:  J Am Soc Mass Spectrom       Date:  1995-04       Impact factor: 3.109

2.  Hsp104 facilitates the endoplasmic-reticulum-associated degradation of disease-associated and aggregation-prone substrates.

Authors:  Lynley M Doonan; Christopher J Guerriero; G Michael Preston; Teresa M Buck; Netaly Khazanov; Edward A Fisher; Hanoch Senderowitz; Jeffrey L Brodsky
Journal:  Protein Sci       Date:  2019-05-20       Impact factor: 6.725

3.  Isolation and characterization of cDNA clones encoding human liver glutamate dehydrogenase: evidence for a small gene family.

Authors:  G Mavrothalassitis; G Tzimagiorgis; A Mitsialis; V Zannis; A Plaitakis; J Papamatheakis; N Moschonas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  Identification of a novel lipid binding motif in apolipoprotein B by the analysis of hydrophobic cluster domains.

Authors:  Scott M Gordon; Mohsen Pourmousa; Maureen Sampson; Denis Sviridov; Rafique Islam; B Scott Perrin; Georgina Kemeh; Richard W Pastor; Alan T Remaley
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-01       Impact factor: 3.747

5.  Conformation and stability properties of B17: II. Analytical investigations using differential scanning calorimetry.

Authors:  Hassan M Khachfe; David Atkinson
Journal:  Eur Biophys J       Date:  2012-12-28       Impact factor: 1.733

6.  Characterization of the promoter elements required for hepatic and intestinal transcription of the human apoB gene: definition of the DNA-binding site of a tissue-specific transcriptional factor.

Authors:  D Kardassis; M Hadzopoulou-Cladaras; D P Ramji; R Cortese; V I Zannis; C Cladaras
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

7.  Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region.

Authors:  E Boerwinkle; W J Xiong; E Fourest; L Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  DNase I- and micrococcal nuclease-hypersensitive sites in the human apolipoprotein B gene are tissue specific.

Authors:  B Levy-Wilson; C Fortier; B D Blackhart; B J McCarthy
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

9.  Cryoelectron microscopy of low density lipoprotein in vitreous ice.

Authors:  J M Spin; D Atkinson
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

10.  Structural relationship of human apolipoprotein B48 to apolipoprotein B100.

Authors:  T L Innerarity; S G Young; K S Poksay; R W Mahley; R S Smith; R W Milne; Y L Marcel; K H Weisgraber
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.